Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination Cover

.blurhash-client-img { display: none !important; }

Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination

Acta Pharmaceutica

Volume 69 (2019): Issue 3 (September 2019)

By: Tanja Rozman Peterka, Tina Trdan Lušin, Jure Bergles, Zoran Ham, Rok Grahek and Uroš Urleb

Open Access

|Jun 2019

Authors

Tanja Rozman Peterka

tanja.rozman_peterka@novartis.com

Lek Pharmaceticals d.d., Ljubljana, Slovenia

Tina Trdan Lušin

Lek Pharmaceticals d.d., Ljubljana, Slovenia

Jure Bergles

Lek Pharmaceticals d.d., Ljubljana, Slovenia

Zoran Ham

Lek Pharmaceticals d.d., Ljubljana, Slovenia

Rok Grahek

Lek Pharmaceticals d.d., Ljubljana, Slovenia

Uroš Urleb

Lek Pharmaceticals d.d., Ljubljana, Slovenia

DOI: https://doi.org/10.2478/acph-2019-0025 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 363 - 380

Accepted on: Dec 29, 2018

|

Published on: Jun 26, 2019

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

forced degradation,

Related subjects:

Pharmacy, other

© 2019 Tanja Rozman Peterka, Tina Trdan Lušin, Jure Bergles, Zoran Ham, Rok Grahek, Uroš Urleb, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 69 (2019): Issue 3 (September 2019)Next article